Noninvasive BCV Target hospitals and care facilities adopting noninvasive ventilation to expand BCV adoption. Highlight the unique externally applied cuirass approach as an alternative to masks and invasive ventilation to address patient tolerance and broaden care pathways.

Clinical Education Leverage HMD’s focus on clinical education and research to create training partnerships, education programs, and certification opportunities that drive clinician engagement and adoption of BCV across diverse care settings.

Global Care Settings Position BCV for hospitals, long-term acute care facilities, and other care environments worldwide where noninvasive options are valued, emphasizing pathway integration and compatibility with existing respiratory care protocols.

Revenue Growth Explore strategic sales motions with mid‑sized health systems and regional networks where a $1M–$10M revenue profile aligns with expanding noninvasive options, offering scalable deployment and service contracts.

Strategic Partnerships Pursue collaborations with larger medical technology players and distributors to enhance market reach, expand product education, and accelerate adoption through established channels and trust networks.